Hn. Hodis et al., THE ROLE OF CAROTID ARTERIAL INTIMA-MEDIA THICKNESS IN PREDICTING CLINICAL CORONARY EVENTS, Annals of internal medicine, 128(4), 1998, pp. 262
Background: Carotid arterial intima-media thickness is used as a nonin
vasive surrogate end point to measure progression of atherosclerosis,
but its relation to coronary events has not been fully explored. Objec
tive: To determine whether carotid arterial intimamedia thickness pred
icts coronary events. Design: Long-term follow-up (average, 8.8 years)
of a previously assembled cohort of persons who completed the 2-year
Cholesterol Lowering Atherosclerosis Study, a randomized arterial imag
ing trial designed to study the effects of lipid lowering on progressi
on of atherosclerosis. Setting: University-based ultrasonography labor
atory. Patients: 146 men 40 to 59 years of age who had previously had
coronary artery bypass graft surgery. Measurements: Preintrusive ather
osclerosis in the common carotid artery was evaluated every 6 months w
ith B-mode ultrasonography, and intrusive atherosclerosis in the coron
ary arteries was evaluated at baseline and at 2 years with quantitativ
e coronary angiography. After the trial, the incidences of coronary ev
ents (nonfatal acute myocardial infarction, coronary death, and corona
ry artery revascularization) were documented. Results: For each 0.03-m
m increase per year in carotid arterial intima-media thickness, the re
lative risk for non-fatal myocardial infarction or coronary death was
2.2 (95 % Cl, 1.4 to 3.6) and the relative risk for any coronary event
was 3.1 (Cl, 2.1 to 4.5) (P < 0.001). Absolute intima-media thickness
was also related to risk for clinical coronary events (P < 0.02). Abs
olute thickness and progression in thickness predicted risk for corona
ry events beyond that predicted by coronary arterial measures of ather
osclerosis and lipid measurements (P < 0.001). Conclusion: Noninvasive
B-mode ultrasonographic measurement of progression of intima-media th
ickness in the distal common carotid artery is a useful surrogate end
point for clinical coronary events.